Fierce Biotech

Novartis, Bristol Myers halt autoimmune CAR-T trials due to adverse events

Novartis and Bristol Myers Squibb have halted several CAR-T trials in autoimmune diseases due to immune-related adverse ...
BioPharma Dive

Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns

Side effects observed in testing have led Novartis to halt development of rap-cel in multiple indications and Bristol Myers ...
BioSpaceOpinion

Opinion: CAR Ts will only treat autoimmune diseases if we can scale delivery

Biopharmas developing CAR T therapies for autoimmune indications face major barriers to maximizing the market. Advances in ...

Autoimmune Diseases

The biotech said some patients developed cancer in a late-stage clinical trial for the bowel-disease drug that was unrelated to the treatment. Find insight on Amazon’s new drug-discovery app, Johnson ...
Medindia on MSN

CAR T cell therapy moves beyond cancer into autoimmune disease

Chennai, Aug. 28 -- Highlights: ...
BioSpaceOpinion

Opinion: CAR T for autoimmune disease benefits from oncology’s lessons—and will deliver its own

Thanks in part to the revolution cell therapy brought to treating blood cancers, the modality is now showing promise in some ...
People

Biohacker Bryan Johnson Reveals He Has a Chronic Autoimmune Disease: ‘My Stomach Is Eating Itself’

Bryan Johnson, who spends $2 million a year on his health, claims his gastritis is linked to his sugary childhood diet, as well as adult stress and depression Bryan Johnson/Instagram Bryan Johnson ...
Managed Healthcare Executive

FDA approves brepocitinib for rare skin disease

The FDA has approved Lisraya (brepocitinib) to treat adults with dermatomyositis, rare autoimmune disease. Dermatomyositis ...